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ABSTRACT
Introduction: The use of activity trackers has increased both among private
consumers and in healthcare. It is therefore relevant to consider whether a
consumer-graded activity tracker is comparable to or may substitute a
research-graded activity tracker, which could further increase the use of activity
trackers in healthcare and rehabilitation. Such use will require knowledge of their
accuracy as the clinical implications may be significant. Studies have indicated that
activity trackers are not sufficiently accurate, especially at lower walking speeds.
The present study seeks to inform decision makers and healthcare personnel
considering implementing physical activity trackers in clinical practice. This study
investigates the criterion validity of the consumer-graded Garmin Vivosmart HR
and the research-graded StepWatch 3 compared with manual step count
(gold standard) at different walking speeds under controlled conditions.
Methods: Thirty participants, wearing Garmin Vivosmart HR at the wrist and
StepWatch 3 at the ankle, completed six trials on a treadmill at different walking
speeds: 1.6 km/h, 2.4 km/h, 3.2 km/h, 4.0 km/h, 4.8 km/h, and 5.6 km/h.
The participants were video recorded, and steps were registered by manual step
count. Medians and inter-quartile ranges (IQR) were calculated for steps and
differences in steps between manually counted steps and the two devices. In order to
assess the clinical relevance of the tested devices, the mean absolute percentage
error (MAPE) was determined at each speed. A MAPE ≤3% was considered to be
clinically irrelevant. Furthermore, differences between manually counted steps and
steps recorded by the two devices were presented in Bland–Altman style plots.
Results: The median of differences in steps between Garmin Vivosmart HR and
manual step count ranged from −49.5 (IQR = 101) at 1.6 km/h to −1 (IQR = 4)
at 4.0 km/h. The median of differences in steps between StepWatch 3 and manual
step count were 4 (IQR = 14) at 1.6 km/h and 0 (IQR = 1) at all other walking speeds.
The results of the MAPE showed that differences in steps counted by Garmin
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Vivosmart HR were clinically irrelevant at walking speeds 3.2–4.8 km/h
(MAPE: 0.61–1.27%) as the values were below 3%. Differences in steps counted by
StepWatch 3 were clinically irrelevant at walking speeds 2.4–5.6 km/h (MAPE:
0.08–0.35%).
Conclusion: Garmin Vivosmart HR tended to undercount steps compared with
the manual step count, and StepWatch 3 slightly overcounted steps compared with
the manual step count. Both the consumer-graded activity tracker (Garmin
Vivosmart HR) and the research-graded (StepWatch 3) are valid in detecting
steps at selected walking speeds in healthy adults under controlled conditions.
However, both activity trackers miscount steps at slow walking speeds, and the
consumer graded activity tracker also miscounts steps at fast walking speeds.
Subjects Kinesiology, Public Health, Translational Medicine
Keywords Validity, Activity tracker, Physical activity, Adults, Steps, Activity monitor
INTRODUCTION
Physical activity, such as walking, is beneficial to the individuals’ health, and physical
activity is known to reduce the risk of musculoskeletal disorders, chronic diseases,
and death (Takacs et al., 2014; Kumahara et al., 2015; Riel et al., 2016). Common
recommendations for healthy adults regarding physical activity are either 30 min of
moderate activity or walking 10,000 steps a day (Haskell et al., 2007; Tudor-Locke et al.,
2011b). Consumer-graded off-the-shelf activity trackers are widely available for private
use, and wearable devices were the top fitness trend worldwide in both 2016, 2017,
2019, and 2020 (Thompson, 2015, 2016, 2018, 2019). Activity trackers are marketed as
objective tools for measuring steps and activity, allowing individuals to monitor daily
activity and, for example, get reminders to increase their activity to reach recommended or
personalized goals (Takacs et al., 2014; Evenson, Goto & Furberg, 2015; Kooiman et al.,
2015; Huang et al., 2016). Activity trackers seem to play a prominent role not only in
objectifying individuals’ physical activity patterns but also in demonstrating and
monitoring changes in activity behavior (Fokkema et al., 2017). As feedback on activity
level and personalized goals might be very important to users, the accuracy of activity
trackers is an important element to consider (Burton et al., 2018; Gaz et al., 2018).
Recent years have seen a growing use of activity trackers among private consumers
and in healthcare (Fokkema et al., 2017) where objective measures of activity can be used
for self-management purposes, prediction of fall risk, and to measure the effect of
rehabilitation programs, etc. (Chigateri et al., 2018). In healthcare, the accuracy of activity
trackers must be known as lack of accuracy may have significant clinical implications
when using activity trackers for various tasks such as monitoring and evaluating patient
progress, supporting the choice of or adjusting interventions, or for machine learning
purposes (Ferguson et al., 2015; Treacy et al., 2017). Activity trackers are typically divided
into two groups; consumer-graded activity trackers and research-graded activity trackers.
One might assume that the latter are better at detecting physical activity, such as steps,
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than the often cheaper consumer-graded activity trackers (Tudor-Locke et al., 2011a;
Ferguson et al., 2015). However, due to the expenses and user requirements of
research-graded activity trackers, it is relevant to consider whether a consumer-graded
activity tracker is comparable to or may substitute a research-graded activity tracker,
which could increase the use of activity trackers in healthcare and rehabilitation.
Studies have indicated that activity trackers are not sufficiently accurate, especially at
lower walking speeds (Crouter et al., 2003; Ryan et al., 2006; Steeves et al., 2011;
Van Remoortel et al., 2012; Fortune et al., 2014; Lee et al., 2015; Huang et al., 2016;
Fokkema et al., 2017; Tedesco et al., 2019). When using activity trackers in healthcare, the
target populations are likely to have different walking speeds with intermittent decreases
in walking (e.g., in rehabilitation after ligament tears) or continued slow walking
(e.g., older or disabled people). This emphasizes the need to be certain about the accuracy
of the activity trackers when using the data in care and treatment of patients (Fokkema
et al., 2017). Thus, lack of accuracy, for example, in the form of overestimation or
underestimation of the number of steps, may interfere with healthcare interventions and
lead to untoward outcomes. Bearing this in mind, the accuracy of activity trackers
must be validated (Lee et al., 2015; Huang et al., 2016). Previous validation studies have
proposed and used different walking speeds. Some have used walking speeds between
2.4 km/h and 6.4 km/h, with intervals of 0.8 km/h (Edbrooke et al., 2012; De Cocker et al.,
2012; Lee et al., 2015; Gaz et al., 2018). However, older or disabled people can have
even lower walking speed than 2.4 km/h (Graham et al., 2010). The aim of the present
study was to determine differences in step count of an off-the-shelf consumer-graded
activity tracker and a research-graded activity tracker to investigate the criterion validity.
This study investigates the criterion validity of the wrist-worn, consumer-graded Garmin
Vivosmart HR and the ankle-worn, research-graded StepWatch 3 compared with
manual step count (gold standard) at different walking speeds under controlled conditions.
By adding to the knowledge base on the criterion validity under controlled conditions, this
study seeks to inform and support decision makers and healthcare personnel when
considering implementing physical activity trackers in clinical practice.
METHODS
This criterion validity study complies with the Guidelines for Reporting Reliability
and Agreement Studies (GRRAS) (Kottner et al., 2011) and follows the taxonomy,
terminology, and definitions from the “COnsensus-based Standards for the selection of
health status Measurement INstruments” (the COSMIN study) (Mokkink et al., 2010a,
2010b).
The choice of sample size, inclusion and exclusion criteria, and treadmill speeds was
guided by the study aim and informed by previous study designs; the latter to facilitate
comparison with other research in this field.
We find it important to investigate the criterion validity in healthy adults under
controlled conditions prior to commencing a study in free-living conditions or in a
non-healthy population.
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Ethics statement
The North Denmark Region Committee on Health Research Ethics stated that according
to ethics committee law number 593 of 14/6/2011 § 2, 1-3 and § 14, 1 (Confirmation
date 02.16.2016), ethical approval was not required for this study. The study was
conducted in accordance with the principles of the Declaration of Helsinki.
Sample size and method
The sample size was set to 30 participants, which was in accordance with equivalent
laboratory condition validation studies (Takacs et al., 2014; Kooiman et al., 2015; Riel et al.,
2016). Two observers conducted data collection, manual step count, data processing, and
statistical analysis. The observers were blinded to the results until all raw data had been
processed and were ready for statistical analysis.
Participants
Thirty healthy adults (n = 18 females, n = 12 males), Table 1, were recruited through the
University College of Northern Denmark by using a mailing list with contact addresses of
students and staff. Verbal and written information on the study procedures and aim
was provided, and written informed consent was obtained from all participants prior to
commencing the study. All participation was voluntary. Data collection was conducted in
April 2016.
Only healthy participants were included. The inclusion and exclusion criteria were in
line with those of previous studies (Hendrick et al., 2010; Steeves et al., 2011; Bergman et al.,
2012; Fortune et al., 2014, 2015; Takacs et al., 2014; Johnson et al., 2015; Stansfield,
Hajarnis & Sudarshan, 2015; Hickey et al., 2015). To ensure physical activity participation
clearance participants were eligible for inclusion if they were: (i) aged 18–64 years
(self-reported), (ii) able to read and comprehend Danish and English (self-reported),
and (iii) responded “No” to all questions (7 out of 7) in the Physical Activity Readiness
Questionnaire (PAR-Q) (Shephard, 1988; Steeves et al., 2011; Johnson et al., 2015).
Moreover, (iv) for safety reasons, participants should be able to walk independently
>40 min (self-reported) to ensure that they were able to complete the treadmill walking
exercise without risking adverse events (e.g., injury). Criteria for exclusion were:
(i) neurological diseases (self-reported), (ii) cognitive problems (self-reported), (iii) any
musculoskeletal injuries and/or operation (self-reported) that might have affected walking
six weeks prior to participation, and (iv) vascular issues (self-reported) since these may
influence walking ability (Takacs et al., 2014; Stansfield, Hajarnis & Sudarshan, 2015;
Fortune et al., 2015).
Table 1 Demographical data.
Gender (N, men/women) 12/18
Age (years, mean (SD)) 26.6 (±6.2)
Height (cm, mean (SD)) 173.9 (±10.7)
Weight (kg, mean (SD)) 73.8 (±12.4)
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Garmin Vivosmart HR
The Garmin Vivosmart HR (Garmin, Olathe, Kansas, USA: 149,99 USD (Garmin, 2016a)
is a wrist-worn, accelerometer-based off-the-shelf activity tracker monitoring step count,
distance, calories, heart rate, number of floors climbed and intensity minutes. The Garmin
Vivosmart HR has a build-in display for direct operation and reading of data. Data
storage and analysis from the Garmin Vivosmart HR can be assessed by the user through
a Garmin Connect account enabling optional settings (e.g., Health & Fitness, Units).
(Garmin, 2016b). To configure the Garmin Vivosmart HR through Garmin Express
v. 4.1.19.0, a Garmin Connect account was created with the Health & Fitness profile
enabled. The Garmin Connect account was solely used to login to the Garmin Express
v. 4.1.19.0 software to configure the activity tracker for each participant individually
(Garmin, 2016b, 2016c). The Garmin Vivosmart HR was configured individually for
each participant by entering his or her date of birth, gender, weight, and height. Metric
values were used during this configuration process, time was presented in 24-h format, and
the lowest activity level (standard value) was chosen for all participants. The standard
option for the wearing side for the activity tracker was set to “left” in the Garmin Express
v. 4.1.19.0 software. The Garmin Vivosmart HR was placed proximally from the caput
ulnae sinister on each participant, as recommended by the manufacturer (Fig. 1)
(Garmin, 2016c).
StepWatch 3
The StepWatch 3 (Modus Health, LLC, Edmonds, WA, USA: 525 USD (Accelerometer),
1470 USD (Docking station and software) (Tudor-Locke et al., 2011a)) is an ankle-worn,
accelerometer-based, research-graded activity tracker monitoring step count and
activity levels based on step rate. A docking station and software are needed to configure
the StepWatch 3 and access the recorded data (Tudor-Locke et al., 2011a; Modus
Health, 2014). The StepWatch 3 was configured individually for each participant by
entering gender, height, weight, and age. Furthermore, the recording interval was defined
to 15 s and Client ID and Trial ID were entered for subsequent data analysis. The two
StepWatch 3 monitors (one on each leg) were mounted according to the manufacturer’s
recommendation just proximal from the malleolus lateralis of the ankle (Fig. 2) (Modus
Health, 2014).
Video recording and manual step count
Manual step count is regarded the gold standard for step counting during treadmill
walking in laboratory conditions (Tudor-Locke et al., 2002; Fortune et al., 2014, 2015;
Lee et al., 2015; Stansfield, Hajarnis & Sudarshan, 2015; Sellers et al., 2016). Thus,
manual step count was used during walking on a zebris FDM-T treadmill
(zebris Medical GmbH, Isny, Germany). In this study, a GoPro Hero 4 Black Edition
(GoPro, Inc., San Mateo, CA, USA) was used to record treadmill walking. The camera was
placed so that the participant’s sagittal plane was recorded.
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In this study, a step was defined in accordance with Hickey and colleagues as “when the
foot was completely raised off and subsequently lowered to the ground” (Hickey et al.,
2015). Using this definition, the two observers individually viewed the recordings using
Figure 1 Illustration of the placement of Garmin Vivosmart HR.
Full-size DOI: 10.7717/peerj.9381/fig-1
Figure 2 Illustration of the placement of StepWatch 3 monitors. (A) Frontal view, (B) Sagittal
view. Full-size DOI: 10.7717/peerj.9381/fig-2
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 6/19
VLC version 2.2.4 (VideoLAN, Paris, France) while using a hand tally (Rucanor BSI
ISO 09001 Certified No. FM40047) ensuring blinding and double validation of the manual
step counting based on the approach in similar studies (Rosenkranz, Rosenkranz &Weber,
2011; Aminian & Hinckson, 2012; Takacs et al., 2014; Riel et al., 2016). In cases of
discrepancies between the two observers’ step counts, a new counting was performed to
ensure valid counts as done by Takacs et al. (2014).
Procedure of the treadmill test
In order to examine the criterion validity of Garmin Vivosmart HR and StepWatch 3
in step counting under controlled conditions, the participants were asked to perform six
trials with a total sum of 40 minutes of treadmill walking at various speeds. Thus, to
capture both very low, low, moderate, and high walking speeds, paces of 1.6 km/h,
2.4 km/h, 3.2 km/h, 4.0 km/h, 4.8 km/h, and 5.6 km/h were chosen, based on the
approaches of previous studies (Edbrooke et al., 2012;De Cocker et al., 2012; Lee et al., 2015;
Gaz et al., 2018). However, none of these studies included walking speeds below 2.4 km/h.
We therefore found it particularly relevant to include the 1.6 km/h walking speed in
this study as the use of activity trackers in healthcare may include target populations with
intermittent decreases in walking speed (e.g., rehabilitation after ligament tears) or
continued slow walking speeds (e.g., older or disabled people). In line with previous studies,
each participant familiarized him or herself with the equipment before the actual test
(Ryan et al., 2006; Giannakidou et al., 2012), walking the six different speeds for 2 min each
to gain experience with the acceleration and deceleration of the treadmill.
As suggested in previous studies, a test period of 5 min per speed was used
(Le Masurier & Tudor-Locke, 2003; Crouter et al., 2003; Ryan et al., 2006; Giannakidou
et al., 2012; De Cocker et al., 2012; Takacs et al., 2014). An interval time break of 90 s
was used to allow time to record data from the Garmin Vivosmart HR and make a
break in the recording of the StepWatch 3. The procedure for the interval time
break was based on previous treadmill walking studies (Bergman et al., 2012; Lee et al.,
2015). Increases and decreases in speed in each trial were programed to 0.91 m/s and
were included in the 5-min test period. For safety reasons, verbal countdown from
the observer was given 10, 5, and 3 s prior to the starting and stopping event.
The treadmill was set to an elevation of 0 degrees verified by a spirit level, in line
with similar studies (Le Masurier & Tudor-Locke, 2003; Steeves et al., 2011).
As recommended by the manufacturer, service and calibration of the treadmill’s pressure
sensors and speedometer were performed prior to this study by an employe at zebris
Medical GmbH (2015). The tests were carried out in the Movement Laboratory,
Department of Physiotherapy, University College of Northern Denmark, Aalborg,
Denmark.
Processing data
Garmin Vivosmart HR: Start and stop values of step count recorded by the activity
tracker were collected manually before and after every trial and transferred into a
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Microsoft Office Excel Datasheet. The actual number of steps recorded by the activity
tracker was calculated by subtracting the start value from the stop value.
StepWatch 3: When the participant had completed all trials, data were downloaded for
both StepWatch 3 activity trackers with software provided by the manufacturer—
StepWatch v.3.4. Data were exported with the software StepWatch v.3.4 into a
Microsoft Office Excel Datasheet, where the sum of recorded steps by the two StepWatch
3 activity trackers was identified for each trial.
Video data from the GoPro Hero 4 Black Edition were transferred using the associated
application/software GoPro Desktop v1.3.0.2371, available from the manufacturer’s
web page (GoPro, 2016). Data from each walking speed were registered using a visual speed
indicator and saved as separate files for subsequent identification. The video recordings
were used as the underlying technical basis for manual step count.
Statistical analysis
All statistical analyses were conducted in R version 3.6.1 and RStudio version 1.2.1335.
The criterion validity of Garmin Vivosmart HR and StepWatch 3 was established by a
series of statistical tests applying a significance level of p < 0.05.
The Shapiro–Wilk test was used to determine the distribution of normality of the
differences between Garmin Vivosmart HR and manual step count, and between
StepWatch 3 and manual step count. The Shapiro–Wilk test showed events of
non-normality (p < 0.05); therefore, non-parametric tests were applied for further
statistical analysis. Medians and inter-quartile ranges (IQR) were calculated by the default
settings in R for steps and differences in steps between manually counted steps and the two
devices.
In order to assess the clinical relevance of the tested devices, the mean absolute percentage
error (MAPE) was determined at each walking speed for Garmin Vivosmart HR and
StepWatch 3. The MAPE was calculated as MAPE ¼ Activity trackerManual Countj jManual Count  100%.
Earlier studies have described a MAPE ≤3% to be clinically irrelevant (Holbrook,
Barreira & Kang, 2009; Colley et al., 2013; Johnson et al., 2015; Liu et al., 2015; Riel et al.,
2016; Bunn et al., 2018). The differences between manually counted steps and steps recorded
by the two devices were presented in Bland Altman style plots along with the median,
the 2.5th, and the 97.5th quartile due to the non-normally distributed dataset (Gialamas
et al., 2010; Riel et al., 2016). All data were plotted, and no potential outliers were removed.
RESULTS
Garmin Vivosmart HR vs. manual step count
The medians of differences in steps between Garmin Vivosmart HR and manual step
count were −49.5 (IQR = 101) at 1.6 km/h, −7.5 (IQR = 14) at 2.4 km/h, −2.5 (IQR = 6)
at 3.2 km/h, −1 (IQR = 4) at 4.0 km/h, −1 (IQR = 5) at 5.8 km/h, and −4 (IQR = 7) at
5.6 km/h (Table 2). These are plotted in the Bland–Altman style plot (Fig. 3).
The results of the MAPE showed that the steps counted by Garmin Vivosmart HR
had clinically relevant deviations at 1.6 km/h, 2.4 km/h, and 5.6 km/h (MAPE:
3.49–26.35%) compared with manual step count (Table 2). The differences in step count
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for the device were interpreted as being clinically irrelevant as the values were below 3% at
walking speeds of 3.2–4.8 km/h (MAPE: 0.61–1.27%).
StepWatch 3 vs. manual step count
The medians of differences in steps between StepWatch 3 and manual step count were
4 (IQR = 14) at 1.6 km/h and 0 (IQR = 1) at 2.4 km/h, 3.2 km/h, 4.0 km/h, 4.8 km/h, and
5.6 km/h (Table 2). These are plotted in the Bland–Altman style plot (Fig. 4).
The results of the MAPE showed that the steps counted by StepWatch 3 had a
clinically relevant deviation at 1.6 km/h (MAPE: 3.60%) compared with manual step count
(Table 2). The differences in step count for the device were interpreted clinically irrelevant
as the values were below 3% at walking speeds of 2.4–5.6 km/h (MAPE: 0.08–0.35%).
DISCUSSION
This study aimed to investigate the criterion validity of Garmin Vivosmart HR and
StepWatch 3 at different walking speeds under controlled conditions. The results showed
a tendency towards Garmin Vivosmart HR undercounting steps compared with manual
step count, and StepWatch 3 slightly overcounted steps compared with manual step
count.
Table 2 The median of counted steps by device, and the median of differences in steps by device
compared to manual step count, and the mean absolute percentage error by device compared to
manual step count.
Device Walking
speed (km/h)
Median
(steps)
Median of
difference (steps)
Mean absolute
percentage
error (%) ± SD
Manual step count 1.6 337.5 (IQR = 33) – –
2.4 410 (IQR = 29) – –
3.2 473 (IQR = 38) – –
4.0 529.5 (IQR = 40) – –
4.8 574 (IQR = 46) – –
5.6 608 (IQR = 49) – –
Garmin Vivosmart HR 1.6 292.5 (IQR = 106) −49.5 (IQR = 101) 26.35 (±23.63)
2.4 398 (IQR = 34) −7.5 (IQR = 14) 3.49 (±4.10)
3.2 465 (IQR = 36) −2.5 (IQR = 6) 1.27 (±1.67)
4.0 527 (IQR = 37) −1 (IQR = 4) 0.61 (±0.61)
4.8 570 (IQR = 45) −1 (IQR = 5) 0.61 (±0.68)
5.6 577 (IQR = 53) −4 (IQR = 47) 6.45 (±11.46)
StepWatch 3 1.6 345 (IQR = 22) 4 (IQR = 14) 3.60 (±6.03)
2.4 412 (IQR = 29) 0 (IQR = 1) 0.35 (±1.00)
3.2 473.5 (IQR = 36) 0 (IQR = 1) 0.09 (±0.12)
4.0 529.5 (IQR = 40) 0 (IQR = 1) 0.08 (±0.09)
4.8 574 (IQR = 47) 0 (IQR = 1) 0.08 (±0.10)
5.6 608.5 (IQR = 49) 0 (IQR = 1) 0.09 (±0.12)
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Figure 3 Bland Altman style plot illustrating the differences between Garmin Vivosmart HR and manual step count at walking speeds from
1.6 km/h to 5.6 km/h. (A) 1.6 km/h, (B) 2.4 km/h, (C) 3.2 km/h, (D) 4.0 km/h, (E) 4.8 km/h, (F) 5.6 km/h.
Full-size DOI: 10.7717/peerj.9381/fig-3
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Figure 4 Bland Altman style plot illustrating the differences between StepWatch 3 andmanual step count at walking speeds from 1.6 km/h to
5.6 km/h. (A) 1.6 km/h, (B) 2.4 km/h, (C) 3.2 km/h, (D) 4.0 km/h, (E) 4.8 km/h, (F) 5.6 km/h. Full-size DOI: 10.7717/peerj.9381/fig-4
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Despite their tendencies to undercount and overcount steps, the activity trackers
may still be clinically relevant at some walking speeds when a cut point of a MAPE ≤3% is
used (Holbrook, Barreira & Kang, 2009; Colley et al., 2013; Johnson et al., 2015; Liu et al.,
2015; Riel et al., 2016). The results showed that both Garmin Vivosmart HR and
StepWatch 3 miscounted steps at slow walking speeds, and that Garmin Vivosmart HR
miscounted steps at fast walking speeds as well. Taking this into account, we find that
Garmin Vivosmart HR is valid for counting steps at walking speeds from 3.2 km/h
to 4.8 km/h and close to the cut point at walking speed of 2.4 km/h with a MAPE of 3.49%.
If the aim is to walk 10,000 steps per day, Garmin Vivosmart HR would miscount
349 daily steps at a walking speed of 2.4 km/h. However, the MAPE also shows that
Garmin Vivosmart HR is far from valid when counting steps at very slow and fast
walking speeds. Old people tend to walk slower than younger healthy people and many
also reduce their physical activity level (Burton et al., 2018). Accurate measuring of walking
speed and amount of walking is important because both speed and amount of walking are
associated with health outcome in older people (Graham et al., 2010; Lee et al., 2019).
However, at a slow walking speed of 1.6 km/h, Garmin Vivosmart HR would miscount
around ¼ of all steps, which makes it highly unreliable in a clinical setting with patient
groups walking at slow speeds.
When assessing MAPE for StepWatch 3, we found that this device is more valid
in detecting steps than Garmin Vivosmart HR at all walking speeds. StepWatch 3 only
exceeds the cut point slightly at a walking speed of 1.6 km/h with a MAPE of 3.60%.
This supports previous findings stating that StepWatch is one of the most accurate
activity trackers for step counting at slow walking speeds (Lim et al., 2018). Both devices
showed difficulties in counting steps, especially at slow walking speeds, which supports the
results of previous studies of activity trackers (Crouter et al., 2003; Steeves et al., 2011;
Van Remoortel et al., 2012; Fortune et al., 2014; Fokkema et al., 2017; Bunn et al., 2018;
Gaz et al., 2018). A plausible explanation suggested in previous studies of other activity
trackers may be that the algorithm used for step detection at slow walking speeds was
insufficient (Taraldsen et al., 2011; Fortune et al., 2014) and that very slow walking
therefore may not generate sufficient acceleration for registration by accelerometery
(Fokkema et al., 2017; Gaz et al., 2018). It is a challenge that the step-detection algorithm is
a closed source in most consumer activity trackers because this prevents analysis of how
the accelerometer raw data are processed. Another general issue is that some activity
trackers are updated or become outdated before validation studies are published (Bunn
et al., 2018). It should be noted that Garmin Vivosmart HR has been discontinued
(Garmin, 2020). Garmin’s newest Vivosmart is the Garmin Vivosmart 4, and due to the
closed source firmware, it is unknown but also unlikely that newer devices are programed
with the same firmware as older models. In general, it should be mentioned that
manufacturers frequently update their software. Ongoing optimization and perfection of
algorithms are likely to affect activity detection and thereby step counts. Therefore, the
results of this study should be interpreted with consideration to the software versions at the
time of data collection; 18–27th of April 2016.
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The different placements of the activity trackers may also affect their ability to detect
steps. Anderson and colleagues found that the placement of the accelerometer affects
the criterion validity; that is, ankle-mounted devices seem valid, whereas thigh-worn
devices are not considered valid using ActiGraph GT3X for step counting among
ward-based adults (Anderson, Yoward & Green, 2019). In addition, studies of hip-based
activity trackers have found that these devices provide more accurate step counts than
wrist-based trackers (Gaz et al., 2018). Due to its placement on the wrist, the accelerometer
in Garmin Vivosmart HR will primarily be affected by arm swing and upper body
movement, whereas the accelerometer in StepWatch 3 is more likely to be affected by
shuffling, stride length, etc., due to its placement on the ankle.
As mentioned previously, manual step count is considered the gold standard in
laboratory conditions, but measuring daily steps in free-living conditions by manual
step count would be very impractical. Results indicate that the research-graded
StepWatch 3 is the best device for measuring step count in free-living conditions
due to its accuracy at both slow and fast walking speeds. However, the cheaper,
consumer-graded Garmin Vivosmart HR can be used in a target population with a
narrower range of walking speeds, from relatively slow to moderately fast walking
speeds (3.2–4.8 km/h). If the target population meets the criteria for walking speeds of
Garmin Vivosmart HR, using this device could be a cost-benefit-balanced approach to
measuring steps. This information could aid decision makers and healthcare personnel
when considering to implement physical activity trackers in clinical practice and provide
an indication on whether they might consider using a consumer-graded activity tracker
instead of a research-graded activity tracker in their target population in relation to
walking speed.
Strengths and limitations
The use of different walking speeds under controlled conditions in general and the
inclusion of walking speed down to 1.6 km/h in particular are considered a strength of
the present study since this has not previously been addressed sufficiently in criterion
validity studies. Very slow walking speeds are typically found in older or disabled people;
however, the results of the present study cannot be directly compared to older people as only
healthy younger adults participated in our study. The gait pattern in younger people may
differ from the gait pattern in older people (Burton et al., 2018). The present study only
investigated step detection under controlled conditions in straight treadmill walking, and it
should be noted that sensitivity and specificity may be very different in free-living conditions
and in people with disabilities and alternate walking patterns, for instance.
This study adds to the knowledge base on criterion validity of step count under
controlled conditions for consumer and research-graded activity trackers. Even though
this study investigates the criterion validity of two specific activity trackers, the findings
may guide decision makers and healthcare personnel’s choice when implementing and
applying activity trackers in clinical practice.
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Future work
Future studies should validate and compare consumer and research-graded activity
trackers in free-living conditions and include non-healthy participants whose movement
patterns and mobility disorders might influence the ability of the activity trackers to detect
steps (Steeves et al., 2011; Stansfield, Hajarnis & Sudarshan, 2015; Fokkema et al., 2017;
Burton et al., 2018). Furthermore, it would be relevant to investigate the ability of the
activity trackers to detect steps and reject non-steps in activities such as getting in/out of
bed, sitting and raising from a chair, jumping, etc., to expand knowledge on the ability of
the activity trackers to discriminate steps from other free-living activities in different
populations.
CONCLUSION
This study concludes that both the consumer-graded off-the-shelf activity tracker
(Garmin Vivosmart HR) and the research-graded activity tracker (StepWatch 3) are
valid in detecting steps at selected walking speeds in healthy adults under controlled
conditions. However, both activity trackers miscount steps at slow walking speeds,
and the consumer-graded off-the-shelf activity tracker also miscounts steps at fast
walking speeds. Even though the results reflect the criterion validity of two specific
activity trackers under controlled conditions, the findings may inform and support
decision makers and healthcare personnel when implementing physical activity
trackers and deciding whether to use a consumer-graded or a research-graded activity
tracker.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
The authors received no funding for this work.
Competing Interests
The authors declare that they have no competing interests.
Author Contributions
 Frederik Rose Svarre conceived and designed the experiments, performed the
experiments, analyzed the data, prepared figures and/or tables, authored or reviewed
drafts of the paper, and approved the final draft.
 Mads Møller Jensen conceived and designed the experiments, performed the
experiments, authored or reviewed drafts of the paper, and approved the final draft.
 Josephine Nielsen conceived and designed the experiments, authored or reviewed drafts
of the paper, and approved the final draft.
 Morten Villumsen analyzed the data, authored or reviewed drafts of the paper, and
approved the final draft.
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 14/19
Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
The North Denmark Region Committee on Health Research Ethics stated that ethical
approval was not required for this study (Confirmation date 02.16.2016).
Data Availability
The following information was supplied regarding data availability:
Raw data and code are available in the Supplemental Files.
Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/10.7717/
peerj.9381#supplemental-information.
REFERENCES
Aminian S, Hinckson EA. 2012. Examining the validity of the ActivPAL monitor in measuring
posture and ambulatory movement in children. International Journal of Behavioral
Nutrition and Physical Activity 9(1):119 DOI 10.1186/1479-5868-9-119.
Anderson JL, Yoward LS, Green AJ. 2019. A study investigating the validity of an accelerometer in
quantification of step count in adult hospital inpatients recovering from critical illness.
Clinical Rehabilitation 33(5):936–942 DOI 10.1177/0269215519829893.
Bergman RJ, Spellman JW, Hall ME, Bergman SM. 2012. Is there a valid app for that? Validity of
a free pedometer iPhone application. Journal of Physical Activity & Health 9(5):670–676
DOI 10.1123/jpah.9.5.670.
Bunn JA, Navalta JW, Fountaine CJ, Reece JD. 2018. Current state of commercial wearable
technology in physical activity monitoring 2015–2017. International Journal of Exercise Science
11:503–515.
Burton E, Hill KD, Lautenschlager NT, Thøgersen-Ntoumani C, Lewin G, Boyle E, Howie E. 2018.
Reliability and validity of two fitness tracker devices in the laboratory and home environment for
older community-dwelling people. BMC Geriatrics 18(1):103 DOI 10.1186/s12877-018-0793-4.
Chigateri NG, Kerse N, Wheeler L, MacDonald B, Klenk J. 2018. Validation of an accelerometer
for measurement of activity in frail older people. Gait & Posture 66:114–117
DOI 10.1016/j.gaitpost.2018.08.024.
Colley RC, Barnes JD, Leblanc AG, Borghese M, Boyer C, Tremblay MS. 2013. Validity of the
SC-StepMX pedometer during treadmill walking and running. Applied Physiology, Nutrition,
and Metabolism 38(5):520–524 DOI 10.1139/apnm-2012-0321.
Crouter SE, Schneider PL, Karabulut M, Bassett DR. 2003. Validity of 10 electronic pedometers
for measuring steps, distance, and energy cost. Medicine and Science in Sports and Exercise
35(8):1455–1460 DOI 10.1249/01.MSS.0000078932.61440.A2.
De Cocker KA, De Meyer J, De Bourdeaudhuij IM, Cardon GM. 2012. Non-traditional wearing
positions of pedometers: validity and reliability of the Omron HJ-203-ED pedometer under
controlled and free-living conditions. Journal of Science and Medicine in Sport/Sports Medicine
Australia 15(5):418–424 DOI 10.1016/j.jsams.2012.02.002.
Edbrooke L, Lythgo N, Goldsworthy U, Denehy L. 2012. Can an accelerometer-based monitor be
used to accurately assess physical activity in a population of survivors of critical illness?
Global Journal of Health Science 4(3):98–107 DOI 10.5539/gjhs.v4n3p98.
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 15/19
Evenson KR, Goto MM, Furberg RD. 2015. Systematic review of the validity and reliability of
consumer-wearable activity trackers. International Journal of Behavioral Nutrition and Physical
Activity 12(1):159 DOI 10.1186/s12966-015-0314-1.
Ferguson T, Rowlands AV, Olds T, Maher C. 2015. The validity of consumer-level, activity
monitors in healthy adults worn in free-living conditions: a cross-sectional study.
International Journal of Behavioral Nutrition and Physical Activity 12(1):42
DOI 10.1186/s12966-015-0201-9.
Fokkema T, Kooiman TJM, Krijnen WP, Van Der Schans CP, De Groot M. 2017. Reliability and
validity of ten consumer activity trackers depend on walking speed. Medicine and Science in
Sports and Exercise 49(4):793–800 DOI 10.1249/MSS.0000000000001146.
Fortune E, Lugade VA, Amin S, Kaufman KR. 2015. Step detection using multi-versus single
tri-axial accelerometer-based systems. Physiological Measurement 36(12):2519–2535
DOI 10.1088/0967-3334/36/12/2519.
Fortune E, Lugade V, Morrow M, Kaufman K. 2014. Validity of using tri-axial accelerometers
to measure human movement—Part II: step counts at a wide range of gait velocities.
Medical Engineering & Physics 36(6):659–669 DOI 10.1016/j.medengphy.2014.02.006.
Garmin. 2016a. vivosmart HR | Garmin | Fitness Tracker. Available at https://buy.garmin.com/en-
US/US/into-sports/health-fitness/vivosmart-hr/prod531166.html (accessed 16 May 2016).
Garmin. 2016b. Sports Features | Garmin Connect. Available at https://connect.garmin.com/en-US/
features/ (accessed 7 May 2016).
Garmin. 2016c. Garmin owner’s: Vivosmart HR manual. Olathe: Garmin Ltd.
Garmin. 2020. Previous Models Fitness Trackers | Garmin. Available at https://buy.garmin.com/
en-US/US/cIntoSports-c571-c10668-p1.html (accessed 12 April 2020).
Gaz DV, Rieck TM, Peterson NW, Ferguson JA, Schroeder DR, Dunfee HA,
Henderzahs-Mason JM, Hagen PT. 2018. Determining the validity and accuracy of multiple
activity-tracking devices in controlled and free-walking conditions. American Journal of Health
Promotion 32(8):1671–1678 DOI 10.1177/0890117118763273.
Gialamas A, Laurence CO, Yelland LN, Tideman P, Worley P, Shephard MD, Tirimacco R,
Willson KJ, Ryan P, Gill J, Thomas DW, Beilby JJ, Members of the PoCT Trial Management
Committee. 2010. Assessing agreement between point of care and laboratory results for lipid
testing from a clinical perspective. Clinical Biochemistry 43(4–5):515–518
DOI 10.1016/j.clinbiochem.2009.11.014.
Giannakidou DM, Kambas A, Ageloussis N, Fatouros I, Christoforidis C, Venetsanou F,
Douroudos I, Taxildaris K. 2012. The validity of two Omron pedometers during treadmill
walking is speed dependent. European Journal of Applied Physiology 112(1):49–57
DOI 10.1007/s00421-011-1951-y.
GoPro. 2016. GoPro Desktop App - Easily offload and enjoy your GoPro photos and videos, make
quick edits and share your favorite shots. Available at http://shop.gopro.com/softwareandapp/
gopro-app-%7C-desktop/GoPro-Desktop-App.html# (accessed 7 May 2016).
Graham JE, Fisher SR, Bergés I-M, Kuo Y-F, Ostir GV. 2010. Walking speed threshold for
classifying walking independence in hospitalized older adults. Physical Therapy
90(11):1591–1597 DOI 10.2522/ptj.20100018.
Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW,
Thompson PD, Bauman A. 2007. Physical activity and public health: updated recommendation
for adults from the American College of Sports Medicine and the American Heart Association.
Medicine and Science in Sports and Exercise 39(8):1423–1434 DOI 10.1249/mss.0b013e3180616b27.
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 16/19
Hendrick P, Boyd T, Low O, Takarangi K, Paterson M, Claydon L, Milosavljevic S. 2010.
Construct validity of RT3 accelerometer: a comparison of level-ground and treadmill walking at
self-selected speeds. Journal of Rehabilitation Research and Development 47(2):157–168
DOI 10.1682/JRRD.2009.04.0047.
Hickey A, John D, Sasaki JE, Mavilia M, Freedson P. 2015. Validity of activity monitor step
detection is related to movement patterns. Journal of Physical Activity & Health 13(2):145–153
DOI 10.1123/jpah.2015-0203.
Holbrook EA, Barreira TV, Kang M. 2009. Validity and reliability of Omron pedometers for
prescribed and self-paced walking. Medicine and Science in Sports and Exercise 41(3):670–674
DOI 10.1249/MSS.0b013e3181886095.
Huang Y, Xu J, Yu B, Shull PB. 2016. Validity of FitBit, Jawbone UP, Nike+ and other wearable
devices for level and stair walking. Gait & Posture 48:36–41 DOI 10.1016/j.gaitpost.2016.04.025.
Johnson M, Meltz K, Hart K, Schmudlach M, Clarkson L, Borman K. 2015.Validity of the actical
activity monitor for assessing steps and energy expenditure during walking. Journal of Sports
Sciences 33(8):769–776 DOI 10.1080/02640414.2014.964747.
Kooiman TJM, Dontje ML, Sprenger SR, Krijnen WP, Van der Schans CP, De Groot M. 2015.
Reliability and validity of ten consumer activity trackers. BMC Sports Science, Medicine and
Rehabilitation 7(1):24 DOI 10.1186/s13102-015-0018-5.
Kottner J, Audigé L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, Roberts C, Shoukri M,
Streiner DL. 2011. Guidelines for reporting reliability and agreement studies (GRRAS) were
proposed. Journal of Clinical Epidemiology 64(1):96–106 DOI 10.1016/j.jclinepi.2010.03.002.
Kumahara H, Ayabe M, Ichibakase M, Tashima A, Chiwata M, Takashi T. 2015. Validity of
activity monitors worn at multiple nontraditional locations under controlled and free-living
conditions in young adult women. Applied Physiology, Nutrition, andMetabolism 40(5):448–456
DOI 10.1139/apnm-2014-0183.
Le Masurier GC, Tudor-Locke C. 2003. Comparison of pedometer and accelerometer accuracy
under controlled conditions. Medicine and Science in Sports and Exercise 35(5):867–871
DOI 10.1249/01.MSS.0000064996.63632.10.
Lee I-M, Shiroma EJ, Kamada M, Bassett DR, Matthews CE, Buring JE. 2019. Association of step
volume and intensity with all-cause mortality in older women. JAMA Internal Medicine
179(8):1105 DOI 10.1001/jamainternmed.2019.0899.
Lee JA, Williams SM, Brown DD, Laurson KR. 2015. Concurrent validation of the Actigraph gt3x
+, Polar active accelerometer, Omron HJ-720 and Yamax Digiwalker SW-701 pedometer step
counts in lab-based and free-living settings. Journal of Sports Sciences 33(10):991–1000
DOI 10.1080/02640414.2014.981848.
Lim SER, Ibrahim K, Sayer AA, Roberts HC. 2018. Assessment of physical activity of hospitalised
older adults: a systematic review. Journal of Nutrition, Health & Aging 22(3):377–386
DOI 10.1007/s12603-017-0931-2.
Liu S, Brooks D, Thomas S, Eysenbach G, Nolan RP. 2015. Lifesource XL-18 pedometer for
measuring steps under controlled and free-living conditions. Journal of Sports Sciences
33(10):1001–1006 DOI 10.1080/02640414.2014.981847.
Modus Health. 2014. StepWatch 3 activity monitor & USB docking station—Version 3.4 user
manual. Washington, D.C.: Modus Health.
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM,
De Vet HCW. 2010a. The COSMIN checklist for assessing the methodological quality of studies
on measurement properties of health status measurement instruments: an international Delphi
study. Quality of Life Research 19(4):539–549 DOI 10.1007/s11136-010-9606-8.
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 17/19
Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM,
De Vet HCW. 2010b. The COSMIN study reached international consensus on taxonomy,
terminology, and definitions of measurement properties for health-related patient-reported
outcomes. Journal of Clinical Epidemiology 63(7):737–745 DOI 10.1016/j.jclinepi.2010.02.006.
Riel H, Rathleff CR, Kalstrup PM, Madsen NK, Pedersen ES, Pape-Haugaard LB, Villumsen M.
2016. Comparison between mother, ActiGraph wGT3X-BT, and a hand tally for measuring
steps at various walking speeds under controlled conditions. PeerJ 4(1):e2799
DOI 10.7717/peerj.2799.
Rosenkranz RR, Rosenkranz SK, Weber C. 2011. Validity of the Actical accelerometer step-count
function in children. Pediatric Exercise Science 23(3):355–365 DOI 10.1123/pes.23.3.355.
Ryan CG, Grant PM, Tigbe WW, Granat MH. 2006. The validity and reliability of a novel activity
monitor as a measure of walking. British Journal of Sports Medicine 40(9):779–784
DOI 10.1136/bjsm.2006.027276.
Sellers C, Dall P, Grant M, Stansfield B. 2016. Validity and reliability of the activPAL3 for
measuring posture and stepping in adults and young people. Gait & Posture 43:42–47
DOI 10.1016/j.gaitpost.2015.10.020.
Shephard RJ. 1988. PAR-Q, Canadian home fitness test and exercise screening alternatives.
Sports Medicine 5(3):185–195 DOI 10.2165/00007256-198805030-00005.
Stansfield B, Hajarnis M, Sudarshan R. 2015. Characteristics of very slow stepping in healthy
adults and validity of the activPAL3 activity monitor in detecting these steps.
Medical Engineering & Physics 37(1):42–47 DOI 10.1016/j.medengphy.2014.10.003.
Steeves JA, Tyo BM, Connolly CP, Gregory DA, Stark NA, Bassett DR. 2011. Validity and
reliability of the Omron HJ-303 tri-axial accelerometer-based pedometer. Journal of Physical
Activity & Health 8(7):1014–1020 DOI 10.1123/jpah.8.7.1014.
Takacs J, Pollock CL, Guenther JR, Bahar M, Napier C, Hunt MA. 2014. Validation of the Fitbit
One activity monitor device during treadmill walking. Journal of Science and Medicine in
Sport/Sports Medicine Australia 17(5):496–500 DOI 10.1016/j.jsams.2013.10.241.
Taraldsen K, Askim T, Sletvold O, Einarsen E, Bjåstad K, Indredavik B, Helbostad J. 2011.
Evaluation of a body-worn sensor system to measure physical activity in older people with
impaired function. Physical Therapy 91(2):277–285 DOI 10.2522/ptj.20100159.
Tedesco S, Sica M, Ancillao A, Timmons S, Barton J, O’Flynn B. 2019. Accuracy of
consumer-level and research-grade activity trackers in ambulatory settings in older adults.
PLOS ONE 14(5):e0216891 DOI 10.1371/journal.pone.0216891.
Thompson WR. 2015. Worldwide survey of fitness trends for 2016: 10th Anniversary Edition.
ACSM’s Health & Fitness Journal 19(6):9–18 DOI 10.1249/FIT.0000000000000164.
Thompson WR. 2016. Worldwide survey of fitness trends for 2017. ACSM’s Health & Fitness
Journal 20(6):8–17 DOI 10.1249/FIT.0000000000000252.
Thompson WR. 2018. Worldwide survey of fitness trends for 2019. ACSM’s Health & Fitness
Journal 22(6):10–17 DOI 10.1249/FIT.0000000000000438.
Thompson WR. 2019. Worldwide survey of fitness trends for 2020. ACSM’s Health & Fitness
Journal 23(6):10–18 DOI 10.1249/FIT.0000000000000526.
Treacy D, Hassett L, Schurr K, Chagpar S, Paul SS, Sherrington C. 2017. Validity of different
activity monitors to count steps in an inpatient rehabilitation setting. Physical Therapy
97(5):581–588 DOI 10.1093/ptj/pzx010.
Tudor-Locke C, Bassett DR, Shipe MF, McClain JJ. 2011a. Pedometry methods for assessing
free-living adults. Journal of Physical Activity & Health 8(3):445–453 DOI 10.1123/jpah.8.3.445.
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 18/19
Tudor-Locke C, Craig CL, Brown WJ, Clemes SA, De Cocker K, Giles-Corti B, Hatano Y,
Inoue S, Matsudo SM, Mutrie N, Oppert J-M, Rowe DA, Schmidt MD, Schofield GM,
Spence JC, Teixeira PJ, Tully MA, Blair SN. 2011b. How many steps/day are enough? For
adults. International Journal of Behavioral Nutrition and Physical Activity 8(1):79
DOI 10.1186/1479-5868-8-79.
Tudor-Locke C, Williams JE, Reis JP, Pluto D. 2002. Utility of pedometers for assessing physical
activity: convergent validity. Sports Medicine 32(12):795–808
DOI 10.2165/00007256-200232120-00004.
Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, Langer D,
Glendenning A, Hopkinson NS, Vogiatzis I, Peterson BT, Wilson F, Mann B, Rabinovich R,
Puhan MA, Troosters T, PROactive consortium. 2012. Validity of activity monitors in health
and chronic disease: a systematic review. International Journal of Behavioral Nutrition and
Physical Activity 9(1):84 DOI 10.1186/1479-5868-9-84.
zebris Medical GmbH. 2015. FDM-T technical specifications and user manual. Isny im Allgä: zebris
Medical GmbH.
Svarre et al. (2020), PeerJ, DOI 10.7717/peerj.9381 19/19
